GoodRx Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated November 10, 2021, announces the financial results for GoodRx Holdings, Inc. for the three and nine months ended September 30, 2021. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the furnished press release (Exhibit 99.1) and letter to shareholders (Exhibit 99.2), which are not included in the provided text.
Material Changes
The filing does not detail specific material changes versus prior periods. It serves as a notification that the results for the period ended September 30, 2021, have been announced.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, and contingencies are referenced as being available in the furnished Exhibits 99.1 and 99.2. The filing explicitly states that the information in Item 2.02 and these exhibits is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Review the full text of the Press Release (Exhibit 99.1) for specific revenue and profit figures.
- Consult the Letter to Shareholders (Exhibit 99.2) for management's outlook and strategic commentary.
- Verify the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Note that the financial data in this 8-K is furnished and not legally "filed" under Section 18 of the Exchange Act.